Cargando…
Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration
Substantial challenges in study design and methodology exist during clinical trial development to examine treatment response in patients with a rare disease, especially those with predominant central nervous system involvement and heterogeneity in clinical manifestations and natural history. Here we...
Autores principales: | Videnovic, Aleksandar, Pfeiffer, Helle C. V., Tylki-Szymańska, Anna, Berry-Kravis, Elizabeth, Ezgü, Fatih, Ganju, Jitendra, Jurecka, Agnieszka, Lang, Anthony E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032345/ https://www.ncbi.nlm.nih.gov/pubmed/36970548 http://dx.doi.org/10.3389/fneur.2023.1098454 |
Ejemplares similares
-
Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2020) -
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
por: Marshall, Randall D., et al.
Publicado: (2019) -
Diagnosis and Treatment of Pantothenate Kinase-Associated Neurodegeneration (PKAN): A Systematic Review
por: Pohane, Meera R, et al.
Publicado: (2023) -
Pantothenate Kinase-Associated Neurodegeneration (PKAN) With Concomitant Blepharospasm: Unveiling a Clinical Enigma
por: Reddy, Venkat, et al.
Publicado: (2023) -
A Scale to Assess Activities of Daily Living in Pantothenate Kinase‐Associated Neurodegeneration
por: Marshall, Randall D., et al.
Publicado: (2019)